By establishing a permanent pandemic clinic, the Netherlands will be prepared for the next pandemic. Construction can begin as far as a consortium of companies is concerned.
The use of tech in the healthcare industry isn’t about replacing the need for humans – it’s about technology working alongside people in order to deliver the best care possible.
Environmental stress accelerates skin aging. The exact mechanisms are still unclear and form the subject of a research project involving the fashion and cosmetics group Chanel.
Thanks to a new biosensor, medication doses can be automatically regulated based on a patient's condition. Lives can be saved by continuously monitoring the concentration levels of medicines in blood.
By constructing artificial chromosomes inside of yeast, yeast cells will soon have the ability to make a variety of medicines.
Researchers at the University of Bonn, Germany, together with international colleagues, have found and further developed novel antibody fragments, so-called "nanobodies", against the SARS-CoV-2 virus.
A worldwide race is underway to find a method that speeds up medical diagnostics, makes them more convenient and cheaper. Spanish start-up Droplite is one of the contenders aiming to enter the market.
"With higher education and real-life experience on their resume, nurses can become future leaders of healthcare"
Prof. Dr. Sathak Misra from the Surgical Robotics Laboratory is receiving an ERC scholarship. With this grant, researchers at the lab will develop a system for robotic surgery operated by magnets.
Aeson is a temporary solution for patients who are awaiting a heart transplant. The French company Airbus has a role in its development.
Dutch and German scientists have now found a way to accurately detect early-onset Alzeheimer's Disease and consequently develop medication that can be administered more effectively earlier on.
Scientists at the University of Seville may have found the reason why COVID-19 patients do not notice a life-threatening oxygen deficiency - or notice it much too late.
Jelmer Visser tracks for Innovation Origins the movements of the coronary pandemic in Europe. This week: which countries score best (and worst) in vaccinating their population?
Apart from a lot of misery, the corona crisis also yields plenty of new insights into the treatment of other diseases.
Researchers within the Dutch WAVES study are analyzing and influencing uterine waves to increase the likelihood of pregnancy during fertility treatments.
Twenty percent of the Dutch population does not want to take the corona vaccine out of a fear of needles. AINAR offers a solution in the form of a game app.
Cell therapy producer Lonza cultivates anti-cancer drugs on the Chemelot campus from the cells of patients' bodies. In five years time, automated factories in hospitals should be able to do this too.
Sertraline slows down the production of certain amino acids. This makes it possible to fight cancer without harming healthy cells.
Scientists at the Technical University of Munich have developed self-learning algorithms that can help in the analysis and interpretation of biological imaging data in the future.
This is how innovation works: ‘Corona boosts the digitalization of public health and the medical sector’
IO regularly speaks to innovation leaders, trendsetters who are high on the innovation ladder. In this series they offer look behind the scenes in their world. Today: Carmen van Vilsteren.